STRS Ohio’s NantHealth, Inc NH Stock Holding History

STRS Ohio’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-140	Closed	-$27K	–	2005
2016 Q3	$27K	Buy	+140	New	+$25.8K	﹤0.01%	1825

Other funds holding NH

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

STRS Ohio's NH Position: Q4 2016 in Review

STRS Ohio sold out of NantHealth, Inc (NH) in Q4 2016, closing a stake of 140 shares — an estimated $27K sold.

STRS Ohio first reported a position in NH in Q3 2016 and held it in 1 quarter. The position peaked at $27K in Q3 2016. 44 funds tracked by Wall St. Rank hold NH as of Q4 2016.

STRS Ohio reported no remaining NantHealth, Inc position as of Q4 2016 after selling out during the quarter.
STRS Ohio sold 140 NantHealth, Inc shares in Q4 2016, an estimated $27K.
STRS Ohio first reported a position in NantHealth, Inc in Q3 2016 and held it in 1 quarter.
STRS Ohio's NantHealth, Inc position peaked at $27K in Q3 2016.
44 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2016.

Based on STRS Ohio's 13F filing for Q4 2016, filed 24 Jan 2017.